FI962506A - Skötsel av psoriasis - Google Patents

Skötsel av psoriasis Download PDF

Info

Publication number
FI962506A
FI962506A FI962506A FI962506A FI962506A FI 962506 A FI962506 A FI 962506A FI 962506 A FI962506 A FI 962506A FI 962506 A FI962506 A FI 962506A FI 962506 A FI962506 A FI 962506A
Authority
FI
Finland
Prior art keywords
psoriasis
treatment
hyperkeratotic
pharmaceutical composition
dermatoses
Prior art date
Application number
FI962506A
Other languages
English (en)
Finnish (fi)
Other versions
FI962506A0 (sv
FI117001B (sv
Inventor
Joel A Sequeira
Imtiaz A Chaudry
Edwin A Peets
Daniel J Tanner
Eugene L Taylor
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962506A publication Critical patent/FI962506A/sv
Publication of FI962506A0 publication Critical patent/FI962506A0/sv
Application granted granted Critical
Publication of FI117001B publication Critical patent/FI117001B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962506A 1993-12-21 1996-06-17 Förfarande för framställning av farmaceutisk blandning effektiv för vård av psoriasis FI117001B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17105193A 1993-12-21 1993-12-21
US17105193 1993-12-21
PCT/US1994/014165 WO1995017196A1 (en) 1993-12-21 1994-12-19 Psoriasis treatment
US9414165 1994-12-19

Publications (3)

Publication Number Publication Date
FI962506A true FI962506A (sv) 1996-06-17
FI962506A0 FI962506A0 (sv) 1996-06-17
FI117001B FI117001B (sv) 2006-05-15

Family

ID=22622295

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962506A FI117001B (sv) 1993-12-21 1996-06-17 Förfarande för framställning av farmaceutisk blandning effektiv för vård av psoriasis

Country Status (22)

Country Link
EP (1) EP0735885B1 (sv)
JP (2) JP3830963B2 (sv)
KR (1) KR100361240B1 (sv)
CN (1) CN1055392C (sv)
AT (1) ATE271896T1 (sv)
AU (1) AU701833B2 (sv)
CA (1) CA2179628C (sv)
CZ (1) CZ283932B6 (sv)
DE (1) DE69433923T2 (sv)
ES (1) ES2221928T3 (sv)
FI (1) FI117001B (sv)
HK (1) HK1008814A1 (sv)
HU (1) HU226621B1 (sv)
IL (1) IL112019A (sv)
MY (1) MY111719A (sv)
NO (1) NO310854B1 (sv)
NZ (1) NZ278198A (sv)
PL (1) PL178427B1 (sv)
SK (1) SK280766B6 (sv)
TW (1) TW442281B (sv)
WO (1) WO1995017196A1 (sv)
ZA (1) ZA9410143B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
JP4101464B2 (ja) * 1998-08-26 2008-06-18 塩野義製薬株式会社 抗炎症軟膏剤
GR1006093B (el) * 2007-09-07 2008-10-06 Γεωργιος Καλλιμανης Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης
NZ591093A (en) * 2008-10-30 2012-02-24 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
JP2005139210A (ja) 2005-06-02
IL112019A (en) 2000-02-17
CN1055392C (zh) 2000-08-16
EP0735885A1 (en) 1996-10-09
NZ278198A (en) 1997-12-19
FI962506A0 (sv) 1996-06-17
CZ283932B6 (cs) 1998-07-15
SK81896A3 (en) 1997-04-09
HUT74460A (en) 1996-12-30
MY111719A (en) 2000-11-30
FI117001B (sv) 2006-05-15
NO962619D0 (no) 1996-06-20
CZ178496A3 (en) 1997-04-16
AU701833B2 (en) 1999-02-04
HU226621B1 (en) 2009-04-28
SK280766B6 (sk) 2000-07-11
NO962619L (no) 1996-06-20
JP3830963B2 (ja) 2006-10-11
WO1995017196A1 (en) 1995-06-29
DE69433923D1 (de) 2004-09-02
AU1432895A (en) 1995-07-10
CA2179628A1 (en) 1995-06-29
KR960706345A (ko) 1996-12-09
TW442281B (en) 2001-06-23
CN1138294A (zh) 1996-12-18
EP0735885B1 (en) 2004-07-28
ATE271896T1 (de) 2004-08-15
JPH09506897A (ja) 1997-07-08
IL112019A0 (en) 1995-03-15
ZA9410143B (en) 1995-06-20
NO310854B1 (no) 2001-09-10
DE69433923T2 (de) 2005-07-21
HK1008814A1 (en) 1999-05-21
ES2221928T3 (es) 2005-01-16
HU9601708D0 (en) 1996-08-28
PL315150A1 (en) 1996-10-14
KR100361240B1 (ko) 2003-01-29
PL178427B1 (pl) 2000-04-28
CA2179628C (en) 2000-10-24

Similar Documents

Publication Publication Date Title
AU2282395A (en) Nitric oxide donor composition and method for treatment of anal disorders
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
ATE229533T1 (de) Nitrat-salze als arzneimittel
ATE410158T1 (de) Fulvinsäure und deren verwendung in der behandlung von viralen infektionen
PH31607A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatosis.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
AU6857887A (en) Therapeutic agent
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ZA943808B (en) Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses
NO962619L (no) Psoriasisbehandling
PH31608A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
ES2059264A1 (es) Utilizacion de los nitrovasodilatadores en la preparacion de medicamentos antiinflamatorios y analgesicos de uso topico.
GR3023046T3 (en) Transdermal therapeutic system with pentylene tetrazol as active substance.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
TW336220B (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ITMI930327A0 (it) Composizioni topiche per il trattamento dell'acne e delle dermatiti acneiformi
UA30524A (uk) Мазь для лікування гіперкератозів
UA8280A (uk) Спосіб лікування псоріазу

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117001

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired